,,ii  #aaeth ,,congress  #b;d ,session  
,s4 #bdea  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,february #bf1 
#bjah,mr4 ,cassidy introduced the       
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to require the ,secretary of   
,health and ,human ,services to consider
 ,state analysis and sharing of         
prescription drug monitoring program    
data in determining prescription drug   
monitoring program grants to ,states4   
#a4 ,short title ,this ,act may be cited
 as the ,protection from                
,overprescribing ,act4  #b4             
,consideration in awarding grants to    
support ,state ,p,d,m,ps ,in determining
 whether to award a grant to a ,state in
 support of a ,state prescription drug  
monitoring program1 the ,secretary of   
,health and ,human ,services shall      
consider whether each agency of the     
,state that administers the prescription
 drug monitoring program proactively    

analyzes data available through the     
,state's prescription drug monitoring   
program and provides reports to law     
enforcement agencies1 prescriber        
licensing boards1 and other agencies    
describing any prescribers that         
repeatedly fall outside of expected     
norms or standard practices for the     
prescriber's field4